Pharma stocks: With headwinds of uncertainty over, will they outperform? 7 stocks with an upside potential of up to 43%

When it is Trump, logic usually flies out of the window. There is, indeed, little that is logical about the reciprocal tariffs he has announced. Yet, we were right in our very logical assumption that, because the US cannot afford to hit its broken healthcare system further, it would not impose any tariff on imports of pharmaceuticals. Pharma has indeed been exempted from the swathe of tariffs imposed by Trump. But that’s not the end of the story. We don’t know if sectoral sanctions will come up. More importantly...